MedPath
HSA Product

Anbinex Powder For Injection 500 I.U.

Product approved by Health Sciences Authority (SG)

Basic Information

Anbinex Powder For Injection 500 I.U.

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Regulatory Information

SIN13682P

August 6, 2009

Prescription Only

Therapeutic

INTRAVENOUS

August 10, 2023

June 3, 2025

XB01AB02

Company Information

Active Ingredients

Human Antithrombin

Strength: 500 I.U. per 10ml

Detailed Information

Contraindications

**Contraindications** Hypersensitivity to the active substance or to any of the excipients.

Indication Information

**Therapeutic indications** – Patients with congenital deficiency: 1. Prophylaxis of deep vein thrombosis and thromboembolism in clinical risk situations (especially during surgery or during the peri-partum period), in association with heparin if indicated. 2. Prevention of progression of deep vein thrombosis and thromboembolism in association with heparin as indicated.

© Copyright 2025. All Rights Reserved by MedPath